Thursday May 23, 2019 Change 3.76% Price $0.30
Chart period: 2019-02-25 - 2019-05-23




Social Sentiment for NBY

Today's data is from 1 opinions on StockTwits provided by IEX Cloud.
Bullish vs. Bearish opinions
Weighted Sentiment 0.91

Will NBY stock price go up or down on Fri, 24 May 2019?


NovaBay Pharmaceuticals, Inc Forecast and Stock Analysis

Technical NBY stock analysis for Thursday May 23, 2019.

Sell candidate since 2019-04-25 Loss -69.57%
Shorts 1.88% ( 2019-04-15 )
Insider % n/a
Institutional % 1.20%
Beta 1.27
ROA -76.95%
Price to book USD 4.83
P/E Ratio -0.59
Next Earnings Date 2019-08-07

NovaBay Pharmaceuticals, Inc gained 3.76% in the last trading day ( Thursday, 23rd May 2019 ), rising from $0.29 to $0.30 During day the stock fluctuated 48.15% from a day low at $0.27 to a day high of $0.40. The price has fallen in 8 of the last 10 days and is down by -47.68% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 1.20 million more shares were traded than the day before. In total, 1.67 million shares bought and sold for approximately $498 630.00.

Quick summary:

  • 30 day high of the NBY stock price was $1.22 and low was $0.23.
  • 90 day high was $1.75 and low was $0.23.
  • 52 week high for the NovaBay Pharmaceuticals, Inc - $3.75 and low - $0.23.


NovaBay Pharmaceuticals, Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -61.80% during the next 3 months and, with 90% probability hold a price between $0.06 and $0.26 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Wednesday May 22, 2019, which indicates further gains until a new top pivot has been found. NovaBay Pharmaceuticals, Inc has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. NovaBay Pharmaceuticals, Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.37 and $0.82. A break-up above any of these levels will issue buy signals.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 30 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

NovaBay Pharmaceuticals, Inc finds support from accumulated volume at $0.29.

Support: $0.29 Price: $0.30 Resistance: $0.33


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.13 between high and low, or 48.15%. For the last week, the stock has had a daily average volatility of 26.34%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

26.34 %

Average volatility

Overall risk:

Very Low Low Medium High Very High


NovaBay Pharmaceuticals, Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.

Sell Candidate Upgraded
Stronger Sell Today NBY ranks #3896 as SELL CANDIDATE #3896 Weaker Sell
NBY $0.30 ($0.01 3.76%)
NBY is up $0.01 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for NBY based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for readers.

Click here – the NBY analysis is free »

Will NBY stock price go up or down
on Fri, 24 May 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank